Curileum Discovery is a drug target discovery company in London targeting defective stem cells underpinning serious GI diseases
Curileum Discovery has raised $643K in total funding. The most recent round was Seed. The last funding was announced in March 2023.
Curileum Discovery's investors include Oxford Technology Management.
Curileum Discovery is headquartered in Harrow, United Kingdom.
Curileum Discovery is a drug target discovery company in London targeting defective stem cells underpinning serious GI diseases
Curileum Discovery is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Curileum Discovery — Funding & Investors." VCBacked, March 31, 2023, https://www.vcbacked.co/company/curileum-discovery. Accessed October 29, 2026.
VCBacked. (2023). Curileum Discovery — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/curileum-discovery
{{cite web |title=Curileum Discovery — Funding & Investors |url=https://www.vcbacked.co/company/curileum-discovery |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated